Back
 ABCR  Vol.8 No.1 , January 2019
Histochemical Patterns of Collagenic Fibers in the Benign and Malignant Breast Lesions
Abstract: Cancer is one of the leading causes of death worldwide and breast cancer is the most commonly diagnosed cancer among women. An increased incidence of different types of breast cancer has been reported. This study was designed to evaluate the different types of breast cancer and its possible risk of neoplasmic transformation to an advanced malignant stage from a benign tumor. The histochemical patterns of collagen fibers in the benign and malignant breast lesions were evaluated. From the 50 tissue samples, 25 were malignant breast lesions and 25 were benign breast tumor. Hematoxylin and Eosin (HE), Van Gieson staining were performed to detect a benign and malignant tumor as well as collagen fibers. We found that significant cases after age of 35 were associated with ductal carcinoma while most of the cases within the age of 25 years were associated with fibrocystic changes. The intensity of collagen fiber was higher to Ductal Carcinoma while negative and less intense for Fibroblastic changes. Furthermore, a consistent association of other lesions, such as Lobular Carcinoma, Fibroadenoma, Papilloma and Fat necrosis and noticeable staining for collagen was observed for the different lesion. Our study suggested that women with age of 25 with benign lesion of fibrocystic change and ductal carcinoma are highly susceptible to develop advanced malignant tumor with age. Therefore, quantitative measurement of collagen fiber and regular follow-up are recommended to avoid the possible risk of developing advanced malignant lesions.
Cite this paper: Elasbali, A. (2019) Histochemical Patterns of Collagenic Fibers in the Benign and Malignant Breast Lesions. Advances in Breast Cancer Research, 8, 1-10. doi: 10.4236/abcr.2019.81001.
References

[1]   Siegel, R., Naishadham, D. and Jemal, A. (2012) Cancer Statistics, 2012. CA: Cancer Journal for Clinicians, 62, 10-29.
https://doi.org/10.3322/caac.20138

[2]   Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2015) Global Cancer Statistics, 2012. CA: Cancer Journal for Clinicians, 65, 87-108.
https://doi.org/10.3322/caac.21262

[3]   DeSantis, C., Siegel, R., Bandi, P. and Jemal, A. (2011) Breast Cancer Statistics, 2011. CA: Cancer Journal for Clinicians, 61, 409-418.
https://doi.org/10.3322/caac.20134

[4]   Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F. and He, J. (2016) Cancer Statistics in China, 2015. CA: Cancer Journal for Clinicians, 66, 115-132.
https://doi.org/10.3322/caac.21338

[5]   Ording, A.G., Boffetta, P., Garne, J.P., Nystrom, P.M., Cronin-Fenton, D., Froslev, T. and Lash, T.L. (2015) Relative Mortality Rates from Incident Chronic Diseases among Breast Cancer Survivors—A 14 Year Follow-Up of Five-Year Survivors Diagnosed in Denmark between 1994 and 2007. European Journal of Cancer, 51, 767-775.
https://doi.org/10.1016/j.ejca.2015.02.001

[6]   Tirona, M.T. (2013) Breast Cancer Screening Update. American Family Physician, 87, 274-278.

[7]   Cancer Research UK. (2016) Breast Cancer Survival Statistics 2016.
http://www.cancerresearchuk.org/about-cancer/cancer-symptoms/why-is-early-diagnosis-important

[8]   Dutzu, R., Bedwani, R.N., Vana, J., Baker, H.W. and Murphy, G.P. (1980) Noninvasive Breast Carcinoma: Results of a National Survey by the American College of Surgeons. Annals of Surgery, 192, 139-147.
https://doi.org/10.1097/00000658-198008000-00001

[9]   Lu, P., Weaver, V.M. and Werb, Z. (2012) The Extracellular Matrix: A Dynamic Niche in Cancer. The Journal of Cell Biology, 196, 395-406.
https://doi.org/10.1083/jcb.201102147

[10]   Burke, K., Tang, P. and Brown, E. (2013) Second Harmonic Generation Reveals Matrix Alterations during Breast Tumor Progression. Journal of Biomedical Optics, 18, Article ID: 031106.
https://doi.org/10.1117/1.JBO.18.3.031106

[11]   Provenzano, P.P., Inman, D.R., Eliceiri, K.W., Knittel, J.G., Yan, L., Rueden, C.T., White, J.G. and Keely, P.J. (2008) Collagen Density Promotes Mammary Tumor Initiation and Progression. BMC Medicine, 6, 11-16.
https://doi.org/10.1186/1741-7015-6-11

[12]   Albini, A., Mirisola, V. and Pfeffer, U. (2008) Metastasis Signatures: Genes Regulating Tumor-Microenvironment Interactions Predict Metastatic Behavior. Cancer and Metastasis Reviews, 27, 75-83.
https://doi.org/10.1007/s10555-007-9111-x

[13]   Luparello, C. (2013) Aspects of Collagen Changes in Breast Cancer. Journal of Carcinogenesis and Mutagenesis, S13, 7.

[14]   Calhoun, K.E., Allison, K.H., Kim, J.N., et al. (2014) Chapter 62: Phyllodes Tumors. In: Harris, J.R., Lippman, M.E., Morrow, M. and Osborne, C.K., Eds., Diseases of the Breast, 5th Edition, Lippincott-Williams & Wilkins, Philadelphia, PA.

[15]   Bancroft, J.D. and Gamble, M. (2011) Theory and Practice of Histological Techniques. 6th Edition, Churchill Livingstone, Elsevier, Philadelphia, PA, 135.

[16]   Pandeya, D.R., Rajbhandari, A., Nepal, M., Abdalhabib, E.K., Bhatta, M., Malla, S.S., Upadhyay, L. and Saiem Al Dahr, M.H. (2018) Comparative Study of Serum Lipid Profiles in Nepalese Cancer Patients Attending a Tertiary Care Hospital. Asian Pacific Journal of Cancer Prevention, 19, 491-495.

[17]   Ernster, V.L., Barclay, J., Kerlikowske, K., Wilkie, H. and Ballard-Barbash, R. (2000) Mortality among Women with Ductal Carcinoma in Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program. Archives of Internal Medicine, 160, 953-958.
https://doi.org/10.1001/archinte.160.7.953

[18]   Kopans, D.B. (2003) Re: Detection of Ductal Carcinoma in Situ in Women Undergoing Screening Mammography. Journal of the National Cancer Institute, 95, 487.
https://doi.org/10.1093/jnci/95.6.487

[19]   Guray, M. and Sahin, A.A. (2006) Benign Breast Diseases: Classification, Diagnosis, and Management. Oncologist, 11, 435-449.
https://doi.org/10.1634/theoncologist.11-5-435

[20]   Dupont, W.D. and Page, D.L. (1985) Risk Factors for Breast Cancer in Women with Proliferative Breast Disease. The New England Journal of Medicine, 312, 146-151.
https://doi.org/10.1056/NEJM198501173120303

[21]   Jain, R.K. and Stylianopoulos, T. (2010) Delivering Nanomedicine to Solid Tumors. Nature Reviews Clinical Oncology, 7, 653-664.
https://doi.org/10.1038/nrclinonc.2010.139

 
 
Top